These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 8442229

  • 1. Histological comparison of donor livers and lidocaine metabolism in the utilization of organs for liver transplantation.
    Rosenlof LK, Sawyer RG, Broccoli AV, Ishitani MB, Stevenson WC, Pruett TL.
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1662-3. PubMed ID: 8442229
    [No Abstract] [Full Text] [Related]

  • 2. Lidocaine metabolism as an index of liver function in hepatic transplant donors and recipients.
    Schroeder TJ, Gremse DA, Mansour ME, Theuerling AW, Brunson ME, Ryckman FC, Suchy FJ, Penn I, Alexander JW, Pesce AJ.
    Transplant Proc; 1989 Feb; 21(1 Pt 2):2299-301. PubMed ID: 2652744
    [No Abstract] [Full Text] [Related]

  • 3. Limits of the MEGX test in the selection of liver grafts for transplantation.
    Adam R, Azoulay D, Astarcioglu I, Chiche L, Bao YM, Bonhomme L, Lemoine A, Fredj G, Bismuth H.
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1653-4. PubMed ID: 8442225
    [No Abstract] [Full Text] [Related]

  • 4. Donor hyaluronic acid and MEGX levels do not accurately predict posttransplant liver function.
    Michell ID, Abdulnour I, Pzybylowski G, Bowkett J, Gleeson A, Hardy KJ, Jones RM.
    Transplant Proc; 1993 Oct; 25(5):2888-9. PubMed ID: 8212275
    [No Abstract] [Full Text] [Related]

  • 5. MEGX as a test of donor liver function.
    Balderson GA, Potter JM, Hickman PE, Chen Y, Lynch SV, Strong RW.
    Transplant Proc; 1992 Oct; 24(5):1960-1. PubMed ID: 1412928
    [No Abstract] [Full Text] [Related]

  • 6. Lignocaine metabolism and MEGX production in the liver transplant donor.
    Potter JM, Hickman PE, Balderson G, Lynch SV, Strong R.
    Transplant Proc; 1992 Feb; 24(1):198-9. PubMed ID: 1539243
    [No Abstract] [Full Text] [Related]

  • 7. Prospective multivariate analysis of donor monoethylglycine xylidide (MEGX) testing in liver transplantation. Transplantation Society of Michigan Scientific Studies Committee.
    Woodside KJ, Merion RM, Williams TC.
    Clin Transplant; 1998 Feb; 12(1):43-8. PubMed ID: 9541422
    [Abstract] [Full Text] [Related]

  • 8. Safe use of liver donors with MEGX values less than 90 ng/mL.
    Tesi RJ, Elkhammas EA, Davies EA, Salazar A, Henry ML, Greenson J, Ferguson RM.
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1655-6. PubMed ID: 8442226
    [No Abstract] [Full Text] [Related]

  • 9. Lidocaine metabolite formation in the liver donor as a predictive test for the safe and efficient introduction of cyclosporine in the recipient.
    Azoulay D, Lemoine A, Gries JM, Adam R, Dolizy I, Fredj G, Beaune P, Bismuth H.
    Transplant Proc; 1993 Jun; 25(3):2275-8. PubMed ID: 8516899
    [No Abstract] [Full Text] [Related]

  • 10. Prognostic value of the monoethylglycinexylidide liver function test in assessing donor liver suitability.
    Fairchild R, Solomon H, Contis J, Kaminski D.
    Arch Surg; 1996 Oct; 131(10):1099-102. PubMed ID: 8857911
    [Abstract] [Full Text] [Related]

  • 11. Donor rating in human liver transplantation: correlation of oxygen consumption after revascularization with MEGX formation in donors.
    Burdelski M, Oellerich M, Bornscheuer A, Luebbe N, Ringe B, Lamesch P, Raude E, Raith H, Scheruhn M, Gubernatis G.
    Transplant Proc; 1989 Feb; 21(1 Pt 2):2392-3. PubMed ID: 2652779
    [No Abstract] [Full Text] [Related]

  • 12. Value of an extended monoethylglycinexylidide formation test and other dynamic liver function tests in liver transplant donors.
    Zotz RB, von Schönfeld J, Erhard J, Breuer N, Lange R, Beste M, Goebell H, Eigler FW.
    Transplantation; 1997 Feb 27; 63(4):538-41. PubMed ID: 9047147
    [Abstract] [Full Text] [Related]

  • 13. Functional state of the donor liver and early outcome of transplantation.
    Oellerich M, Burdelski M, Ringe B, Wittekind C, Lamesch P, Lautz HU, Gubernatis G, Beyrau R, Pichlmayr R.
    Transplant Proc; 1991 Feb 27; 23(1 Pt 2):1575-8. PubMed ID: 1989297
    [No Abstract] [Full Text] [Related]

  • 14. Risk factors of preservation injury and prognostic value of reperfusion biopsy in outcome of liver transplantation.
    Bao YM, Adam R, Sebagh M, Reynes M, Bismuth H.
    Transplant Proc; 1996 Feb 27; 28(1):123-5. PubMed ID: 8644141
    [No Abstract] [Full Text] [Related]

  • 15. The clinical importance of conventional and quantitative liver function tests in liver transplantation.
    Tanaka E, Inomata S, Yasuhara H.
    J Clin Pharm Ther; 2000 Dec 27; 25(6):411-9. PubMed ID: 11123494
    [Abstract] [Full Text] [Related]

  • 16. Hepatic lidocaine metabolism is useful in the selection of patients in need of liver transplantation.
    Luketic VA, Shiffman ML, Fisher RA, Sanyal AJ, Purdum PP, Posner MP.
    Transplant Proc; 1993 Feb 27; 25(1 Pt 2):1072-4. PubMed ID: 8442046
    [No Abstract] [Full Text] [Related]

  • 17. Indocyanine green clearance in the evaluation of donor livers.
    Koneru B, Leevy CB, Klein KM, Zweil P, Wilson DJ.
    Transplant Proc; 1993 Apr 27; 25(2):1919-20. PubMed ID: 8470226
    [No Abstract] [Full Text] [Related]

  • 18. The use of lidocaine as a test of liver function in liver transplantation.
    Potter JM, Oellerich M.
    Liver Transpl Surg; 1996 May 27; 2(3):211-24. PubMed ID: 9346651
    [Abstract] [Full Text] [Related]

  • 19. Reliability of the MEGX test in the selection of liver grafts.
    Adam R, Azoulay D, Astarcioglu I, Bao YM, Bonhomme L, Fredj G, Bismuth H.
    Transplant Proc; 1991 Oct 27; 23(5):2470-1. PubMed ID: 1926438
    [No Abstract] [Full Text] [Related]

  • 20. The impact of donor organ quality on postoperative liver function after orthotopic rat liver transplantation.
    Knoop M, Neumann U, Lang M, Neuhaus P.
    Langenbecks Arch Surg; 1998 Mar 27; 383(1):95-8. PubMed ID: 9627178
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.